Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Overweight and obesity management (NG246) NICE
Clinical trials show patients lose an average of 15-22% of body weight over 68 weeks, but individual timelines vary based on genetics, metabolism, and adherence to your personalized dosing schedule
In contrast, earlier trials like the LEADER (liraglutide) and SUSTAIN-6 (semaglutide 1.0 mg) trial enrolled people with type 2 diabetes and high cardiovascular risk
In studies, its given as a once-weekly subcutaneous injection, ideally on the same day each week
Save the intensity for weeks three and four when your body has adapted
US$ 21.03
US$ 20.18
,aspect=ignore)
US$ 21.99
US$ 22.52
US$ 28.30
US$ 23.93
US$ 29.28
